# PROMISE International

> **NCT03321552** · NA · COMPLETED · sponsor: **LimFlow SA** · enrollment: 34 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **PROCEDURE:** Percutaneous deep vein arterialization
- **DEVICE:** LimFlow System

## Key facts

- **NCT ID:** NCT03321552
- **Lead sponsor:** LimFlow SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2025-01-23
- **Final completion:** 2025-01-23
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321552, "PROMISE International". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03321552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*